Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) EBT Margin (2020 - 2025)

Rapid Micro Biosystems' EBT Margin history spans 6 years, with the latest figure at 110.65% for Q4 2025.

  • On a quarterly basis, EBT Margin rose 708.0% to 110.65% in Q4 2025 year-over-year; TTM through Dec 2025 was 140.18%, a 2690.0% increase, with the full-year FY2025 number at 140.18%, up 2690.0% from a year prior.
  • EBT Margin hit 110.65% in Q4 2025 for Rapid Micro Biosystems, up from 146.68% in the prior quarter.
  • Over the last five years, EBT Margin for RPID hit a ceiling of 110.65% in Q4 2025 and a floor of 442.08% in Q1 2021.
  • Historically, EBT Margin has averaged 246.52% across 5 years, with a median of 227.57% in 2023.
  • Biggest five-year swings in EBT Margin: plummeted -77100bps in 2021 and later surged 19969bps in 2023.
  • Tracing RPID's EBT Margin over 5 years: stood at 279.78% in 2021, then tumbled by -34bps to 375.86% in 2022, then surged by 53bps to 176.17% in 2023, then soared by 33bps to 117.73% in 2024, then increased by 6bps to 110.65% in 2025.
  • Business Quant data shows EBT Margin for RPID at 110.65% in Q4 2025, 146.68% in Q3 2025, and 163.14% in Q2 2025.